- Home
- PET vs QNRX Comparison
PET vs QNRX Comparison
Compare PET & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PET
- QNRX
- Stock Information
- Founded
- PET 2015
- QNRX 2018
- Country
- PET United States
- QNRX United States
- Employees
- PET N/A
- QNRX N/A
- Industry
- PET EDP Services
- QNRX Medical/Dental Instruments
- Sector
- PET Technology
- QNRX Health Care
- Exchange
- PET Nasdaq
- QNRX Nasdaq
- Market Cap
- PET 5.9M
- QNRX 5.5M
- IPO Year
- PET N/A
- QNRX N/A
- Fundamental
- Price
- PET $0.13
- QNRX $8.17
- Analyst Decision
- PET Strong Buy
- QNRX
- Analyst Count
- PET 2
- QNRX 0
- Target Price
- PET $4.50
- QNRX N/A
- AVG Volume (30 Days)
- PET 18.1M
- QNRX 3.3K
- Earning Date
- PET 08-06-2025
- QNRX 08-07-2025
- Dividend Yield
- PET N/A
- QNRX N/A
- EPS Growth
- PET N/A
- QNRX N/A
- EPS
- PET N/A
- QNRX N/A
- Revenue
- PET $62,453,000.00
- QNRX N/A
- Revenue This Year
- PET $7.87
- QNRX N/A
- Revenue Next Year
- PET $122.23
- QNRX N/A
- P/E Ratio
- PET N/A
- QNRX N/A
- Revenue Growth
- PET N/A
- QNRX N/A
- 52 Week Low
- PET $0.08
- QNRX $5.01
- 52 Week High
- PET $1.34
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- PET 46.19
- QNRX 40.76
- Support Level
- PET $0.11
- QNRX $8.20
- Resistance Level
- PET $0.14
- QNRX $8.69
- Average True Range (ATR)
- PET 0.03
- QNRX 0.36
- MACD
- PET -0.00
- QNRX -0.10
- Stochastic Oscillator
- PET 10.78
- QNRX 0.00
About PET Wag! Group Co.
Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools and pet wellness plans.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.